About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,028 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,028 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 8,028 trials

WithdrawnSafety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerThe primary purpose of this study is to evaluate the safety and tolerability of the combination therapy of trametinib and docetaxel with growth factor support in Japanese subjects…NCT01938456 UnknownModel to Predict pCR and IrAEs in Early Stage Non-small Cell Lung CancerLung cancer is the chief cause of cancer death.NCT06250829·London, Ontario

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedStudy Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung CancerThis is a phase 2 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) in front-line, PD-L1-high, locally advanced or metastatic Non-Small Cell Lung Cancer…NCT04736173·Columbus, Georgia and 37 others

UnknownEpacadostat (INCB24360) in Combination With Sirolimus in Advanced MalignancyThis is a small phase I study with dose escalation and dose expansion cohorts.NCT03217669·Fairway, Kansas and 1 other

Active not recruitingA Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)This study will enroll adult participants with early-stage (stage II-IIIB) non-small cell lung cancer for whom surgery is planned.NCT06465329·Orange, California and 46 others

CompletedA Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerThe purpose of this study is to establish the safest doses of an investigational drug called MORAb-009 in subjects with pancreatic cancer, mesothelioma, or certain types of…NCT00325494·Baltimore, Maryland and 2 others

UnknownAfatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung CancerThis is a multi-center open-label proof-of-concept study consisting of two parts: PART A - a phase I dose-finding study (3 + 3 classical design) evaluating the RP2D of afatinib in…NCT02450656·Nijmegen, Gelderland and 1 other

Active not recruitingPharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)The primary objective of this study is to demonstrate pharmacokinetic (PK) similarity ABP 234 with pembrolizumab.NCT06430866·San Salvador de Jujuy, Jujuy Province and 127 others

Active not recruitingA Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)A global study to assess the efficacy and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive…NCT03521154·Duarte, California and 117 others

Active not recruitingA Phase II Clinical Trial of Ivonescimab Plus Third-generation EGFR-TKIs in Advanced Non-small Cell Lung Cancer With Gradual or Potential Progression After EGFR-TKIs TreatmentThis is a prospective, single-center, Phase II clinical study designed to explore the efficacy and safety of ivonescimab plus third-generation EGFR-TKIs in patients with advanced…NCT07669051·Jinan, Shandong

Not yet recruitingA Study of DS-3939a in Participants With Solid TumorsThe primary purpose of the study is to evaluate the safety, tolerability, and efficacy of DS-3939a in combination with other anticancer agents or as a monotherapy in participants…NCT07739966

TerminatedVaccine-Based Immunotherapy Regimen For NSCLC and TNBCPart 1of the study will evaluate the safety, pharmacokinetics, pharmacodynamics and immunogenicity of increasing doses of a vaccine-based immunotherapy regimen (VBIR-2) for…NCT03674827·Encinitas, California and 33 others

CompletedEvaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759This is a multi-center, open-label, dose escalation and phase I/II study, consisting of dose escalation in Part A and phase II study in Part B.NCT03360929·Guangzhou, Guangdong and 3 others

RecruitingPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCDESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in patients with HER2…NCT04686305·Duarte, California and 90 others

UnknownCombination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)This is an open label, multi-center, randomized control phase II trial, to compare the efficacy and safety of sintilimab combined with anlotinib versus standard platinum-based…NCT04124731

CompletedEthaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung CancersThioredoxin reductase plays an critical role in lung cancer patients, in vitro study showed that, ethaselen, specific inhibitor of thioredoxin reductase, could inhibit lung cancer…NCT02166242·Changsha, Hunan

UnknownRoutine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon)Routine electronic monitoring of health-related quality of life (REMOQOL) consists of collecting HRQoL patients' data via an electronic device in order to provide these data to…NCT04857970·Besançon

RecruitingDZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)This study tests a combination therapy (i.e., DZD9008 plus bevacizumab) in patients with advanced NSCLC harboring EGFR mutations who have progressed on or after standard of care…NCT06276283·Shanghai, Shanghai Municipality

Active not recruitingA Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung CancerThe purpose of this study is to evaluate the efficacy and safety of QL1706 combined with platinum-based chemotherapy versus tislelizumab combined with platinum-based chemotherapy…NCT05690945·Guangzhou, Guangdong

CompletedSpanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.This is a non-interventional, observational, multicentre, one-arm, non-comparative, and retrospective study.NCT04285866·Santiago de Compostela, A Coruña and 38 others

PreviousPage 2 of 402Next